18 news items
Health Canada Approves KEYTRUDA® for adult patients with locally advanced unresectable or metastatic biliary tract carcinoma, in combination with gemcitabine-based chemotherapy
MRK
9 May 24
improvement versus the placebo with gemcitabine/cisplatin arm in OS. In the study, there was a 17% reduction in the risk of death with pembrolizumab plus
Merck Provides Update on Phase 3 KEYNOTE-B21 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Chemotherapy, With or Without Radiotherapy, for Patients With Newly Diagnosed, High-Risk Endometrial Cancer After Surgery With Curative Intent
MRK
9 May 24
13,250 patient deaths from the disease in 2024. Globally, endometrial cancer is the sixth most common cancer in women and the 15th most common cancer
Jim Cramer Advises Investors To Brace For Economic Slowdown, Shares Tips To Maintain Balanced Portfolio: 'I'm Not Telling You To Relax'
AAPL
BLDR
GOOG
8 May 24
just saying we are going into the valley of death here, and you should fear no evil as long as you have a balanced portfolio."
Cramer
Merck Announces Phase 3 KEYNOTE-811 Trial Met Dual Primary Endpoint of Overall Survival (OS) as First-Line Treatment in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
MRK
1 May 24
(known as the mucosa). Gastric cancer is the fifth most diagnosed cancer and the fifth leading cause of cancer death worldwide, with approximately
Why Australian Cancer Biotech Firm Immutep Stock Is Soaring On Wednesday?
IMMP
MRK
24 Apr 24
worldwide, with 890,000 new cases and 450,000 deaths reported in 2018.
Efti has received FDA Fast Track designation in 1L HNSCC regardless of PD-L1
ng6a47va
MRK
19 Apr 24
of death with pembrolizumab plus chemotherapy (HR=0.78 [95% CI, 0.70-0.87]; p<0.0001) versus chemotherapy alone. The median OS for patients
3o9stxlrx0g6b5sjengjqhahph36sxbt02g mya1x3chxukjm4j51ll9b5j
BMY
JNJ
MRK
10 Apr 24
and this time round, they are turning to the world’s most common causes of death- cancer and heart disease.
Johnson & Johnson
xvtkfdkpctkw1hroufp0lp4hny9mazw34qufjma52df
MRK
4 Apr 24
of cancer death worldwide. In 2022 alone, there were approximately 2.4 million new cases and 1.8 million deaths from lung cancer globally. Non-small cell
y5p7x08n3mkr3asnf0wh1nidbezcqjdqiacxg8 w6vkc1
MRK
28 Mar 24
), reducing the risk of death by 28% (HR=0.72 [95% CI, 0.56-0.93]; one-sided p=0.00517) in patients with resectable stage II, IIIA or IIIB NSCLC versus
b4b5 qcpganvh2p
BMY
MRK
27 Mar 24
improved multiple secondary outcome measures, including reducing the risk of death from any cause or PAH clinical worsening events by 84% versus
ignld auqbzcddb5uh79oj3rbtayjwuuy0cesgtmev1yg
MRK
26 Mar 24
; placebo-adjusted) at Week 24 and significantly improved multiple important secondary outcome measures, including reducing the risk of death from any cause
td6bb7
MRK
15 Mar 24
cervical cancer and about 4,360 deaths from the disease in 2024
a1bc7npaljs
AZN
BMY
JNJ
5 Mar 24
to control the epidemic. Drug overdose was behind 112,000 deaths in 2023, with rates that remain way above pre-pandemic numbers. Although
1ge st28xo8rlp2
ABBV
LVTX
MRK
5 Mar 24
of the leading causes of cancer death globally. The increasing incidence of this cancer across the U.S. and other parts of the world is one
vz4i9e93em8gpqm4iypjyx8iilmpr6t1dk9f767ojxlit hv257g38jxxv3
MRK
23 Feb 24
Lung cancer is the leading cause of cancer death worldwide. In 2022 alone, there were approximately 2.4 million new cases and 1.8 million deaths
owy pfotxhxcc
MRK
MRNA
MYNZ
22 Feb 24
with a standard treatment for melanoma significantly reduces the risk of death and recurrence of the most-deadly type of skin cancer. Along
qrbm8k73e
IOBT
IOVA
MRK
12 Feb 24
and invasive skin cancer, resulting in the majority of skin cancer deaths. Long-term survival for metastatic disease is low; however, most patients are initially
zelvxjdmdpwk311hm7nioziyayjrthv15s6jh75x8 qfar7a1
MRK
12 Feb 24
and 2,000 deaths in Canada in 2023, with the highest mortality rates
- Prev
- 1
- Next